Its accent will be on learning from the European Food Safety Authority (EFSA) opinions that have been generated so far.
“The claims regulation has fundamentally changed the marketing rules for communicating health messages on food products,” said Stefanie Geiser, EAS regulatory affairs manager. “But it has not closed the door. Companies should find ways of benefitting from the use of already approved heath claims and carefully check that their claims dossier and scientific studies conform to EFSA standards before filing a new claims application.”
The event will examine the so-called ‘grey list’ of article 13 opinions where EFSA “insufficient evidence” verdicts offer hope even for rejected dossiers.